Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Epidermal Growth Factor Ointment for Patients With Erlotinib Related Skin Effects

NCT01593995 is registered in ClinicalTrials.gov with Dong-A University Hospital as lead sponsor.

NCT NCT01593995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01593995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Epidermal Growth Factor Ointment for Patients With Erlotinib Related Skin Effects
Lead sponsor
Dong-A University Hospital
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
October 31, 2014
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer, pancreatic cancer